A Taiwanese study involving 141 patients with stage 2 and 3 cancers,18 identified postoperative CEA ≥ 5 ng/mL as the second most important prognostic factor (HR, 2.37) following persistent circulating tumor cells (HR, 11). The gene discussed is CEACAM5; the disease is neoplasm.